BioVaxys Technology (BioVaxys Technology) Total Assets : $1.07 Mil (As of Jul. 2023)

View and export this data going back to 2018. Start your Free Trial

What is BioVaxys Technology Total Assets?

BioVaxys Technology's Total Assets for the quarter that ended in Jul. 2023 was $1.07 Mil.

During the past 12 months, BioVaxys Technology's average Total Assets Growth Rate was -82.00% per year. During the past 3 years, the average Total Assets Growth Rate was 111.10% per year.

During the past 5 years, BioVaxys Technology's highest 3-Year average Total Assets Growth Rate was 339.80%. The lowest was 111.10%. And the median was 225.45%.

Total Assets is connected with ROA %. BioVaxys Technology's annualized ROA % for the quarter that ended in Jul. 2023 was -313.89%. Total Assets is also linked to Revenue through Asset Turnover. BioVaxys Technology's Asset Turnover for the quarter that ended in Jul. 2023 was 0.00.

BioVaxys Technology Total Assets Historical Data

The historical data trend for BioVaxys Technology's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioVaxys Technology Total Assets Chart

BioVaxys Technology Annual Data

Trend

Oct18

Oct19

Oct20

Oct21

Oct22

Total Assets

0.08

0.23

7.91

6.84

0.63

BioVaxys Technology Quarterly Data
	Oct18	Jan19	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23
Total Assets	Get a 7-Day Free Trial															6.10	0.63	0.94	1.97	1.07

BioVaxys Technology Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

BioVaxys Technology's Total Assets for the fiscal year that ended in Oct. 2022 is calculated as

Total Assets	=	Total Equity (A: Oct. 2022 )	+	Total Liabilities (A: Oct. 2022 )
	=	-0.565	+	1.197
	=	0.63

BioVaxys Technology's Total Assets for the quarter that ended in Jul. 2023 is calculated as

Total Assets	=	Total Equity (Q: Jul. 2023 )	+	Total Liabilities (Q: Jul. 2023 )
	=	-0.472	+	1.542
	=	1.07

BioVaxys Technology (OTCPK:BVAXF) Total Assets Explanation

Total Assets is connected with ROA %.

BioVaxys Technology's annualized ROA % for the quarter that ended in Jul. 2023 is

ROA %	=	Net Income (Q: Jul. 2023 )	/	( (Total Assets (Q: Apr. 2023 )	+	Total Assets (Q: Jul. 2023 ))	/ count )
	=	-4.768	/	( (1.968	+	1.07)	/ 2 )
	=	-4.768	/	1.519
	=	-313.89 %

Note: The Net Income data used here is four times the quarterly (Jul. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

BioVaxys Technology's Asset Turnover for the quarter that ended in Jul. 2023 is

	Asset Turnover
=	Revenue (Q: Jul. 2023 )	/	( (Total Assets (Q: Apr. 2023 )	+	Total Assets (Q: Jul. 2023 ))	/ count )
=	0	/	( (1.968	+	1.07)	/ 2 )
=	0	/	1.519
=	0.00

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

BioVaxys Technology Total Assets Related Terms

Thank you for viewing the detailed overview of BioVaxys Technology's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

BioVaxys Technology (BioVaxys Technology) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioVaxys Technology Corp (OTCPK:BVAXF) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

5LB:Germany BIOV:Canada

Address

146 Thirtieth Street, Suite 100, Etobicoke, ON, CAN, M8W 3D4

Website

https://www.biovaxys.com

BioVaxys Technology Corp is a clinical-stage biopharma company. The company develops antiviral and anticancer vaccine platforms to treat SARS-CoV-2 and other viral infections, as well as ovarian cancer and other solid tumor types.